-
Mitigating Therapeutic Inertia of GLP-1 Use in T2D
Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 RAs, have recently garnered significant media attention. Initially developed to improve glycemic control in patients with type 2 diabetes, these medications have also proven to…
-
GLP-1 Injectables for Older Adults
With the increasing interest in and popularity of GLP-1 injectable medications, there is a growing concern about their safety when used with older adults. This article reviews some of the benefits and concerns…